Cashu | News | ADAP

HomeWatchlistNewsSignalsPicks

DJI

-1.23%

SPX

-1.60%

IXIC

-2.24%

FTSE

-0.70%

N225

-0.66%

AXJO

-0.92%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Adaptimmune Therapeutics Plc News

12 Health Care Stocks Moving In Monday's After-Market Session

12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Monday's Pre-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session

about 2 months ago

ADAP Advocacy Airs Commercial to Open National Advocacy Campaign Calling for Reforming the 340B Drug Pricing Program

Feature Image for interests on Advertising, Advocacy Group Opinion, Consumer Defensive, Financial Services from prnewswire.com

AltNovel and 3iQ Launch the Middle East's First Multi-Strategy Digital Assets Fund, the AltNovel Digital Access Portfolio (ADAP)

businesswire.com

ReCode Announces Two Key Additions to Scientific Advisory Board

Feature Image for interests on Healthcare, Stock, Technology from businesswire.com

finance.yahoo.com

The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors

Feature Image for interests on Aethlon Medical, Bristol Myers Squibb, Cancer Tumors, Clinical Trial from finance.yahoo.com

finance.yahoo.com

Adaptimmune Reports Q2 2024 Financial and Business Updates

Feature Image for interests on Adaptimmune, Adaptimmune Therapeutics, Cell Therapy, Healthcare from finance.yahoo.com

finance.yahoo.com

Adaptimmune to Report Q2 2024 Financial and Business Updates on Monday, August 12, 2024

Feature Image for interests on Adaptimmune, Adaptimmune Therapeutics, Financial Results, Forward-Looking Statements from finance.yahoo.com

Stocks

Health Care

adap

Adaptimmune Therapeutics Plc

NASDAQ: ADAP

-0.00 (-0.25%)

0.0801

USD

At close at Aug 01, 20:40 UTC

Latest Cashu News

Adaptimmune Therapeutics Advances T-cell Therapy Innovations in Cancer Treatment

Adaptimmune Therapeutics Plc Advances T-cell Therapy Innovations for Cancer Treatment

Adaptimmune Therapeutics Plc Advances T-cell Therapies with Promising Clinical Trial Results